本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Sonnet BioTherapeutics Holdings, Inc.

1.36
-0.0400-2.86%
盘后1.34-0.0199-1.46%17:51 EDT
成交量:2.23万
成交额:3.05万
市值:416.94万
市盈率:-0.15
高:1.39
开:1.35
低:1.34
收:1.40
数据加载中...
2023/06/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/06/09

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/05/26

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/05/17

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/05/10

重要事件披露

8-K - Current report
2023/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/04/18

重要事件披露

8-K - Current report
2023/03/24

重要事件披露

8-K - Current report
2023/03/10

重要事件披露

8-K - Current report
2023/02/13

重要事件披露

8-K - Current report
2023/02/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/02/13

重要事件披露

8-K - Current report
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/07

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/02/06

SEC问询函

CORRESP [Cover] - Correspondence
2023/02/06

SEC问询函

CORRESP [Cover] - Correspondence
2023/02/06

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2023/01/30

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2023/01/19

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933